Healthcare Sales & Marketing Network News: postherpetic neuralgia

Searching News Database: postherpetic neuralgia

HSMN NewsFeed - 5 Jul 2022
Newly Released Clinical Data Demonstrates Substantial Improvement in Overall Health-Related Quality of Life in Patients with Painful Diabetic Neuropathy Treated with Nevro HFX Spinal Cord Stimulation Therapy
Devices Neurology

HSMN NewsFeed - 19 Jul 2021
Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
Devices Neurology FDA Product Launch

HSMN NewsFeed - 14 Nov 2018
Gr�nenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 31 Aug 2017
Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabalin in Diabetic Peripheral Neuropathic Pain
Biopharmaceuticals

HSMN NewsFeed - 9 Nov 2016
Sorrento Therapeutics Closes Acquisition of Scilex
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 15 Sep 2015
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 13 Apr 2015
Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 3 Jun 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Oct 2013
Acorda Therapeutics Appoints Michael Rogers Chief Financial Officer; David Lawrence Named Chief of Business Operations
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Aug 2012
Depomed Licenses Acuform(R) Patents to Janssen Pharmaceuticals, Inc.
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 18 Jun 2012
XenoPort Appoints Ernest Mario, Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 Jun 2012
GSK and XenoPort Receive FDA Approval for Horizant(R) for Postherpetic Neuralgia
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Jan 2012
NeurogesX Appoints Ronald Martell President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Oct 2011
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2011
NeurogesX Announces Resignation of EVP of Research and Development and Chief Medical Officer Jeffrey K Tobias, MD
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Aug 2011
Spinifex Closes AU$18.25M(~US$19M) Expanded Series B Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Apr 2011
NeurogesX CEO Anthony DiTonno to Retire by Year End
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Mar 2011
FDA Expands Indication for ZOSTAVAX(R), Merck�s Shingles Vaccine, to Include Adults Ages 50 to 59
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Nov 2010
NeurogesX Receives Qutenza(R)-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
Biopharmaceuticals Drug Delivery Reimbursement

HSMN NewsFeed - 15 Jul 2010
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions

HSMN NewsFeed - 4 Jun 2010
Mylan Receives Approval for Generic Version of Neurontin(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 5 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Apr 2010
Qutenza(R) (capsaicin) 8% Patch for Treatment of Post-Shingles Pain Now Available
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 12 Mar 2010
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Feb 2010
NeurogesX Announces Management Team Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Nov 2009
NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Nov 2009
NeurogesX Expands Commercial Operations Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Oct 2009
Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Sep 2009
Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Jul 2009
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jul 2009
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 22 Jun 2009
NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
Biopharmaceuticals Drug Delivery Distribution

HSMN NewsFeed - 10 Jun 2009
NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 2 Jun 2009
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 21 May 2009
NeurogesX Receives European Commission Approval for Qutenza(TM)
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 29 Apr 2009
Lyrica Significantly Reduced Pain and Improved Other Symptoms of Post-Traumatic Peripheral Nerve Pain, New Data Show
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Apr 2009
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Biopharmaceuticals

HSMN NewsFeed - 23 Mar 2009
Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
Biopharmaceuticals Pain Management Regulatory

HSMN NewsFeed - 19 Mar 2009
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jan 2009
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Oct 2008
NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 15 May 2008
CDC Recommends ZOSTAVAX(R), Merck's Shingles Vaccine, for All Appropriate Adults Aged 60 and Older
Biopharmaceuticals

HSMN NewsFeed - 16 Apr 2008
Lyrica Reduced Pain of Fibromyalgia in Patients Regardless of Symptoms of Anxiety or Depression
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Mar 2008
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 9 Oct 2007
NeurogesX Expands Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2007
NeurogesX' NGX-4010 MAA Filed and Accepted for Review by EMEA for Treatment of Peripheral Neuropathic Pain
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 17 Sep 2007
Depomed Announces Reduction in Force
Biopharmaceuticals

HSMN NewsFeed - 5 Sep 2007
NeurogesX Appoints New Director to the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2007
NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
Biopharmaceuticals Pain Management

HSMN NewsFeed - 10 Jul 2007
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 5 Jul 2007
Depomed Reacquires the Rights to ProQuin(R) XR
Biopharmaceuticals Acquisitions Licensing

HSMN NewsFeed - 11 Jun 2007
NeurogesX Completes Enrollment in Phase 3 Clinical Trial for Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 7 Jun 2007
NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
Biopharmaceuticals

HSMN NewsFeed - 29 May 2007
NeurogesX Appoints BioMarin CEO Bienaime as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 May 2007
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 2 Apr 2007
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 12 Mar 2007
Depomed Files Investigational New Drug Application for Gabapentin GR for the Treatment of Postmenopausal Hot Flashes
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 12 Feb 2007
Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug Delivery Technology
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 21 Dec 2006
Depomed Receives $10 Million License Fee from Esprit and Withdraws Arbitration Proceeding
Biopharmaceuticals Licensing Litigation

HSMN NewsFeed - 20 Dec 2006
Depomed Announces Sweeping Interim Victory in Litigation against Ivax
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 18 Dec 2006
Depomed Delivers Notice of Breach and Demand for Arbitration to Esprit Pharma
Biopharmaceuticals Drug Delivery Litigation

HSMN NewsFeed - 18 Sep 2006
Pfizer's Lyrica(R) Approved in Europe for Difficult-to-Treat Nerve Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 6 Sep 2006
NeurogesX Extension Study Indicates Repeat Treatment with Transacin Provides Prolonged Pain Reduction in HIV-Associated Neuropathy
Biopharmaceuticals

HSMN NewsFeed - 23 Aug 2006
Depomed and King Pharmaceuticals Prepare for Launch of Glumetza(TM) as Timely, New ADA Guidelines Are Issued
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 6 Jul 2006
Depomed Names Matthew Gosling Vice President, Legal and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2006
King Pharmaceuticals and Depomed Announce Agreement to Co-Promote Glumetza(TM)
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 13 Jun 2006
NeurogesX Completes Enrollment in Pivotal Phase 3 Postherpetic Neuralgia Trial
Biopharmaceuticals

HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 10 May 2006
Depomed Finalizes Phase III Clinical Trial Protocol for Gabapentin GR(TM)
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 27 Jan 2006
Pfizer's Lyrica Receives Positive Opinion From CHMP for the Treatment of Generalized Anxiety Disorder in Adults
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Jan 2006
Depomed Announces Positive Results of Phase II Clinical Trial for Gabapentin GR(TM) in Postherpetic Neuralgia
Biopharmaceuticals

HSMN NewsFeed - 3 Jan 2006
NeurogesX Appoints Jeffrey Tobias, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 22 additional stories matching:
postherpetic neuralgia
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.